That's paid-for so-called "research". Read Proactive's "assessment" on occasion of the LAST cash raising and then the one before that.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025